Laura Guzman Gomez

Main Pathologies Treated: Soft tissue sarcoma, Lung cancer and Head and neck cancer

Techniques Used:3DCRT, IMRT/VMAT, IGRT, SGRT, DIBH, SBRT

. Sub-Investigator, TRASTS Clinical Trial (Cohorts C & D): Phase I-II multicenter open-label trial of Trabectedin plus Radiotherapy in Soft Tissue Sarcoma patients. EudraCT: 2014-001549-26 | PI: Dr. Javier Martín-Broto

. Sub-Investigator, GEIS-75 (SYNERGIAS) Trial: Phase II trial of trabectedin and low-dose radiotherapy in advanced/metastatic sarcomas. EudraCT: 2019-003103-36 | PI: Dr. Javier Martín-Broto

. Collaborator, GOEPC/SEOR Multicenter Observational Study Stage III non-small cell lung cancer (NSCLC) management in Spain. PIs: Dr. Felipe Couñago, Dr. Paloma Sosa Fajardo, Dr. Javier Luna

. Sub-Investigator, NANORAY-312 Study: Phase III pivotal trial of NBTXR3 + RT ± cetuximab in elderly, platinum-ineligible HNSCC patients. PIs: Jaime Rubio / Alicia Castelo

. Sub-Investigator, XRAY VISION Study: Phase III RCT of xevinapant + RT vs placebo + RT in resected high-risk HNSCC. PI: Jaime Rubio

. Sub-Investigator, PRONTO Feasibility Study Validation of a novel nutritional screening protocol in oncology patients. PI: Jaime Rubio

. Researcher, Molecular Study on ESBL-producing E. coli & K. pneumoniae in Spain. Funded by FIS – Pl11/01117 | Period: 2011–2014 | PI: Luis Martínez-Martínez

. Principal Investigator, "Rapid Diagnosis of Urinary Tract Infection". Comparative analysis of three bacteriuria detection methods. Conducted during the "Diploma in Technological Innovation and Clinical Laboratory Management". Roche Diagnostics – Complutense University of Madrid (2012–2013).

Teaching Collaborator in the Radiation Oncology Department. Actively engaged in the academic training of Radiation Oncology residents and undergraduate medical students from Universidad Autónoma de Madrid (UAM).

. Sánchez-Cabrero D, Rubio-Pérez J, Durá Esteve J, et al. Use of PROtocol for NuTritional risk in Oncology (PRONTO). Cancers, 2025 (in press).

. Martín-Broto J, Olarte-García A, Fernández-Rodríguez R, et al. Trabectedin and low-dose radiation in advanced leiomyosarcoma. Ther Adv Med Oncol, 2024.

. Samper Ots PM, Zapatero Ortuño J, Pedraza Fernández S, et al. Impact of COVID-19 in Spanish radiotherapy departments. Radiother Oncol. 2021; 161:148–151.

. Guzmán-Gómez L, et al. Imported Melioidosis from Colombia. Enferm Infecc Microbiol Clin. 2015; 33(3):214-6.

. Ocampo-Sosa AA, Guzmán-Gómez LP, et al. VIM-2-producing P. monteilii in a Spanish hospital. Antimicrob Agents Chemother. 2015; 59(2):1334-6.

. García-de-la-Fuente C, Guzmán-Gómez L, et al. Respiratory infections by Bordetella bronchiseptica. Diagn Microbiol Infect Dis. 2015; 82(1):20-5.

. ESTRO 2025 Congress (Vienna): Update on hypofractionated RT in STS: Outcomes, pathological response, and acute toxicity.

. ESTRO 2024 Congress (Glasgow): Hypofractionated RT in STS: Pathological response and acute toxicity.

. ESTRO 2021 Congress (Madrid): SBRT for lung cancer: Biopsy-proven vs empirically treated lesions.

. SEOR 2019 Congress (Santiago de Compostela): SBRT in Oligometastatic Disease Management.